India Recombinant Proteins Market: Can "Biopharma SHAKTI"...

agregó una foto Health

2026-02-05 09:14:12 -

India Recombinant Proteins Market: Can "Biopharma SHAKTI" Transform the Nation into the World’s Biologic Pharmacy?

The India Recombinant Proteins Market in 2026 is experiencing a paradigm shift thanks to the "Biopharma SHAKTI" initiative, a $1.2 billion government program aimed at scaling biologic production. This year, the market is moving away from basic generics and toward "High-Value Biologics" and novel recombinant vaccines. This shift is critical for the global Recombinant Proteins Market, as India...

0 Commentarios 0 Acciones 49 Views 0 Vista previa